Tokyo Tape
Sign in
← Chiome Bioscience

Annual report

4583.TEDINET S100T4L7
Period2023-01-01 → 2023-12-31
Filed2024-03-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amended by S100USPT (2024-11-15).

Key figures · 77
MetricValuePeriodScopeSource row
Revenue¥682m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥631m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥713m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥481m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥448m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2023-01-01 → 2023-12-31StandaloneOperating income
Operating income−¥1.3bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.3bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥1.2bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.3bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.8bnat 2023-12-31StandaloneAssets
Total assets¥2.2bnat 2022-12-31StandaloneAssets
Total assets¥2.3bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.5bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥594mat 2023-12-31StandaloneLiabilities
Total liabilities¥425mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥3.1bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.6bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥173,0002023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥35m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥667m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥271m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.9bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-24.622023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.262022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.742021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.062020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.612019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥21.66at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥36.7at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥45.55at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥77.99at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥78.1at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio65.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.4%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio88.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio92.6%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued52,640,200at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued48,423,500at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued40,781,500at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued39,505,200at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued33,283,500at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees51at 2023-12-31StandaloneNumber of employees
Employees49at 2022-12-31StandaloneNumber of employees
Employees49at 2021-12-31dStandaloneNumber of employees
Employees42at 2020-12-31dStandaloneNumber of employees
Employees38at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 19
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2023-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥552m
Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-12-31−¥1.1bn
Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-12-31¥682m
Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-12-31¥682m
Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-12-31¥399m
—segment totalemployeesat 2023-12-3140 pure
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-12-31¥682m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-12-31¥682m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-12-31−¥653m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥2.2bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥472m
Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-12-31−¥1.1bn
Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-12-31¥631m
Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-12-31¥631m
Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-12-31¥349m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-12-31¥631m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-12-31¥631m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-12-31−¥787m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 835
ItemContextValueUnit
Other sgaCurrentYearDuration_NonConsolidatedMember551859000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1607513000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1603764000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1258655000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1205168000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember21000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember19000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember－JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember513000JPY
Subsidy income noiPrior1YearDuration_NonConsolidatedMember20324000JPY
Subsidy income noiCurrentYearDuration_NonConsolidatedMember－JPY
Other noiPrior1YearDuration_NonConsolidatedMember216000JPY
Other noiCurrentYearDuration_NonConsolidatedMember576000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember20561000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember1108000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember1323000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember2069000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember569000JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember3564000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember2751000JPY
Share acquisition rights issuance costs noePrior1YearDuration_NonConsolidatedMember－JPY
Share acquisition rights issuance costs noeCurrentYearDuration_NonConsolidatedMember7705000JPY
Other noePrior1YearDuration_NonConsolidatedMember286000JPY
Other noeCurrentYearDuration_NonConsolidatedMember655000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember5744000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember13180000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1243838000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-1217240000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration_NonConsolidatedMember5977000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration_NonConsolidatedMember2232000JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember5977000JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember2232000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember-1237861000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-1215008000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember5010000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember5010000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember5010000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember5010000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember-1242871000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1220018000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember1515929000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember3115710000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember3115710000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-2773693000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember-2773693000JPY
Cumulative effects of changes in accounting policiesPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember232000JPY
Cumulative effects of changes in accounting policiesPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember232000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_CapitalStockMember1515929000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember3115710000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass